Research Funding Grows Scacer

Research Funding Grows Scacer

Antoine Antoniol/Bloomberg

An employee prepares a chemical reaction for testing pills in a laboratory at a Sanofi-Aventis SA factory in Compiegne, France. and acquisitions. Sanofi, France’s largest drugmaker, used a contingent value right, or CVR, in its purchase of Genzyme Corp earlier this year, giving shareholders of the Cambridge, Massachusetts-based biotech the possibility of receiving an extra $14 a share if certain milestones were met.